ofcardiomyopathyinItalianasymptomatic
childrenwithelectrocardiographicT-wave
inversionatpreparticipationscreening.
Circulation.2012;125(3):529–538.
389.ZaidiA,SheikhN,JongmanJK,etal.Clinical
differentiationbetweenphysiological
remodelingandarrhythmogenicrightventricular
cardiomyopathyinathleteswithmarked
electrocardiographicrepolarizationanomalies.J
AmCollCardiol.2015;65(25):2702–2711.
390.MarcusFI,ZarebaW,CalkinsH,etal.
Arrhythmogenicrightventricular
cardiomyopathy/dysplasiaclinicalpresentation
anddiagnosticevaluation:resultsfromthenorth
Americanmultidisciplinarystudy.Heart
Rhythm.2009;6(7):984–992.
391.LinkMS,LaidlawD,PolonskyB,etal.
VentriculararrhythmiasinthenorthAmerican
multidisciplinarystudyofARVC:predictors,
characteristics,andtreatment.JAmColl
Cardiol.2014;64(2):119–125.
392.BauceB,RampazzoA,BassoC,etal.Clinical
phenotypeanddiagnosisofarrhythmogenic
rightventricularcardiomyopathyinpediatric
patientscarryingdesmosomalgenemutations.
HeartRhythm.2011;8(11):1686–1695.
393.CorradoD,CalkinsH,LinkMS,etal.
Prophylacticimplantabledefibrillatorinpatients
witharrhythmogenicrightventricular
cardiomyopathy/dysplasiaandnoprior
ventricularfibrillationorsustainedventricular
tachycardia.Circulation.2010;122(12):1144–
1152.
394.PerrinMJ,AngaranP,LaksmanZ,etal.Exercise
testinginasymptomaticgenecarriersexposesa
latentelectricalsubstrateofarrhythmogenic
rightventricularcardiomyopathy.JAmColl
Cardiol.2013;62(19):1772–1779.
395.TeskeAJ,CoxMG,DeBoeckBW,etal.
Echocardiographictissuedeformationimaging
quantifiesabnormalregionalrightventricular
functioninarrhythmogenicrightventricular
dysplasia/cardiomyopathy.JAmSoc
Echocardiogr.2009;22(8):920–927.
396.TeskeAJ,CoxMG,TeRieleAS,etal.Early
detectionofregionalfunctionalabnormalitiesin
asymptomaticARVD/Cgenecarriers.JAmSoc
Echocardiogr.2012;25(9):997–1006.
397.HaugaaKH,BassoC,BadanoLP,etal.
Comprehensivemulti-modalityimaging
approachinarrhythmogeniccardiomyopathy-an
expertconsensusdocumentoftheEuropean
associationofcardiovascularimaging.Eur
HeartJCardiovascImaging.2017;18(3):237–
253.
398.teRieleAS,BhonsaleA,JamesCA,etal.
Incrementalvalueofcardiacmagneticresonance
imaginginarrhythmicriskstratificationof
arrhythmogenicrightventricular
dysplasia/cardiomyopathy-associated
desmosomalmutationcarriers.JAmColl
Cardiol.2013;62(19):1761–1769.
399.QuartaG,HusainSI,FlettAS,etal.
Arrhythmogenicrightventricular
cardiomyopathymimics:roleofcardiovascular
magneticresonance.JCardiovascMagnReson.
2013;15:16.
400.CorradoD,WichterT,LinkMS,etal.Treatment
ofarrhythmogenicrightventricular
Cardiomyopathy/dysplasia:aninternationaltask
forceconsensusstatement.Circulation.
2015;132(5):441–453.
401.MarcusGM,GliddenDV,PolonskyB,etal.
Efficacyofantiarrhythmicdrugsin
arrhythmogenicrightventricular
cardiomyopathy:areportfromthenorth
AmericanARVCregistry.JAmCollCardiol.
2009;54(7):609–615.
402.WichterT,PaulM,WollmannC,etal.
Implantablecardioverter/defibrillatortherapyin
arrhythmogenicrightventricular